A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction
Clinical trial NCT06195930 · COMPLETED
Trial details
- NCT number
- NCT06195930
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-18
- Primary completion
- 2024-07-29
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.